Series A

Corporate venturing deal net: 18-22 February 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Calypso Biotech dances through series A round
Merck Group and Johnson & Johnson both invested in a $22.6m round for the autoimmune disease drug developer, six years after it was spun off from Merck Serono.
NSKnox locks up $15m series A
The payment protection software provider received $15m in a round co-led by Microsoft's M12 unit and venture firm Viola Ventures.
Loom spins $11m in series A
The video messaging technology developer has collected $11m in a Kleiner Perkins-led round that also featured existing backer Slack.
Corporates locate Pinpoint for series A round
Pinpoint has launched its software engineering analytics platform following a $13.5m round that featured Bloomberg Beta and Slack Fund.
Arvelle sells investors on $180m series A
Axovant spinoff Arvelle Therapeutics received $180m in the LSP-led series A round, and will focus on the development of a recently licensed epilepsy drug.
Phylagen traces corporates for $14m series A
The environmental microbiome testing kit maker has collected capital from investors including Western Digital Capital, 3M Ventures and Agfunder in its series A round.
Eli Lilly enters Passage Bio in series A round
Passage Bio has launched to develop treatments for diseases affecting the central nervous system, after raising almost $116m in a series A round backed by Lilly Asia Ventures.

Other News

Sciwind blows through series A stage
Legend Capital led a $29.5m round for SciWind, which is developing treatments for metabolic and liver diseases, with backing from Kawin Technology.
Dandelion warms up $16m series A
Geothermal heating and cooling system provider Dandelion Energy received $16m in a Comcast Ventures-led round that included GV and Lennar.
Corporate venturing deal net: 11-15 February 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Arvelle arrives with $100m
Axovant Sciences has spun out its small molecule team into a startup called Arvelle, which will develop an anti-epileptic drug after raising more than $100m in external funding.
Vor roars to $42m series A
Novartis and Johnson & Johnson have contributed to a series A round for Vor Biopharma, an oncology drug developer co-founded by PureTech Health.
RapidDeploy gets $12m funding dispatch
Samsung Next and GreatPoint Ventures supplied series A capital for emergency response software provider RapidDeploy, which recently moved from South Africa to the US.

Editor's Picks

Intel spreads $72m across 12 companies
Intel Capital has revealed investments in 12 US or China-based portfolio companies and a partnership with the NBA.
Intel Capital reaches Horizon in $60m data spree
The unit is set to lead a $100m round for Horizon Robotics as part of $60m investment in data-focused companies, taking its total 2017 spending to almost $570m.
Intel Capital funds three more in Israel
The corporate venturing unit invested $25m to lead early-stage rounds for Velostrata, Sedona Systems and Panoply.io totalling $38.5m.
News round up 11 May 2015
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
test reg

Login